๐Ÿ”ฅ Moderna and Merck's Cancer Vaccine Cleared Phase 3. The Stock Doubled Before Anyone Saw the Numbers.

๐Ÿ”ฅ Moderna and Merck's Cancer Vaccine Cleared Phase 3. The Stock Doubled Before Anyone Saw the Numbers.

Moderna and Merck's personalized mRNA cancer vaccine cleared Phase 3 in 1,137 melanoma patients โ€” and Moderna's stock more than doubled before the full numbers were even released.